Company / Income Tax
Travere Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$988.0K
FY2025
5-year range
-$21.0K / $988.0K
FY2021-FY2025
Trend
+723.3%
vs FY2024
Sector context
#74 of 204
Health Care
What the data says
Income Tax changed +723% YoY in FY2025, a notable deviation from the 9-year average annual change of +205%.
Based on SEC 10-K filings.
$988,000 in FY2025 with a 5-year CAGR of +4.0%.
Increased from $223,000 to $988,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +46.7%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
#131 of 204 in Health CareTop 64% of 204This company $988.0K Sector average $118.7M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, income tax increased 723.3% year-over-year.
- Ranks #74 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $988.0K | +723.3% |
| FY2024 | $120.0K | -46.2% |
| FY2023 | $223.0K | -28.8% |
| FY2022 | $313.0K | +1590.5% |
| FY2021 | -$21.0K | -102.6% |
| FY2020 | $811.0K | -40.7% |
| FY2019 | $1.4M | +114.1% |
| FY2018 | -$9.7M | +17.8% |
| FY2017 | -$11.8M | -378.5% |
| FY2016 | -$2.5M | +79.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026